Abstract
This article provides a summary of the formal retraction of the study "circHIPK3 Promotes Cell Proliferation and Migration of Gastric Cancer by Sponging miR-107 and Regulating BDNF Expression," originally published in OncoTargets and Therapy in 2020. The retraction follows an editorial investigation that identified significant concerns regarding cell line authentication and the availability of original raw data. Consequently, the study's conclusions regarding the circHIPK3/miR-107/BDNF axis in gastric cancer are no longer considered scientifically valid.
Introduction
In 2020, a research group published findings suggesting that the circular RNA circHIPK3 played a pivotal role in the progression of gastric cancer. The study hypothesized that circHIPK3 functioned as a competitive endogenous RNA (ceRNA), or "molecular sponge," for microRNA-107 (miR-107). By binding to miR-107, circHIPK3 was thought to prevent the microRNA from downregulating the expression of Brain-Derived Neurotrophic Factor (BDNF), a protein associated with cell growth and survival. The authors concluded that this pathway significantly enhanced the proliferation and migratory capabilities of gastric cancer cells.
However, the integrity of these findings has been called into question, leading to a formal retraction by the journal OncoTargets and Therapy.
The Investigation and Retraction Process
The retraction was the result of a rigorous editorial review process. Concerns were initially raised regarding the "non-verifiable" nature of the cell lines used in the experiments. In response, the journal's editors requested the following from the authors:
- Authentication Documentation: Proof of purchase and Short Tandem Repeat (STR) profiling to verify the identity and purity of the cell lines.
- Original Raw Data: The underlying data and unedited images for the figures presented in the paper.
While the authors were reported to be cooperative, the information provided was deemed incomplete and insufficient to verify the study's experimental foundation. Following the guidelines set forth by the Committee on Publication Ethics (COPE), the journal determined that the validity of the research could not be maintained.
Implications for Cancer Research
The retraction of this study underscores several critical issues in contemporary biomedical research:
1. The Necessity of Cell Line Authentication
The use of misidentified or contaminated cell lines is a well-documented source of irreproducibility in cancer research. Without definitive proof of a cell line's identity (typically via STR profiling), any observed molecular interactions or phenotypic changes cannot be reliably attributed to the specific cancer type under study.
2. Data Transparency and Provenance
Scientific advancement relies on the ability of other researchers to verify and build upon published work. The inability to provide original raw data—the "provenance" of the research—renders the findings unverifiable. Modern publishing standards increasingly require that raw data be archived and accessible to ensure transparency.
3. Maintaining the Scholarly Record
Retractions are a vital, albeit unfortunate, part of the scientific process. By watermarking the original article as "Retracted," the journal maintains a transparent history of the literature while alerting the community that the specific claims regarding circHIPK3 and miR-107 in this context should no longer be cited or relied upon.
Conclusion
The formal retraction of the article (Wei J, Xu H, Wei W, et al. Onco Targets Ther. 2020;13:1613–1624) serves as a reminder of the importance of rigorous data management and biological material verification. Researchers are advised to treat the proposed circHIPK3/miR-107/BDNF pathway in gastric cancer as unsupported by the evidence originally presented in this retracted work.
Summary updated